Ukrainian Anti-Cancer Institute,Austria
Dr. Wassil Nowicky — Dipl. Ing., Dr. techn., DDDr. h. c., Director of “Nowicky Pharma” and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). Has finished his study at the Radio technical Faculty of the Technical University of Lviv (Ukraine) with the end of 1955 with graduation to “Diplomingeniueur” in 1960 which title was nostrificated in Austria in 1975. The inventor of the anticancer preparation on the basis of celandine alkaloids “NSC-631570”. Author of over 300 scientific articles dedicated to cancer research. Dr. Wassil Nowicky is a real member of the New York Academy of Sciences, member of the European Union for applied immunology and of the American Association for scientific progress, honorary doctor of the Janka Kupala University in Hrodno, doctor “honoris causa” of the Open international university on complex medicine in Colombo, honorary member of the Austrian Society of a name od Albert Schweizer. He has received the award for the merits of the National guild of pharmacists in America.The award of the Austrian Society of sanitary, hygiene and public health services and others.
Novartis Oncology/Columbia University, New York, USA.
Dr. Hanna Dobrowolska has expertise in modern cancer treatment. She is a subject matter expert in the area of biomarkers, immunology and tumor biology. Her core expertise is immuno-oncology with a major focus in hematology. Dr. Dobrowolska’s contribution to the development of clinical biomarker strategies for cancer diagnosis and therapies resulted in launching first-ever cell & gene therapy in the United States treating patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-ALL). During her longstanding years of experience in clinical research, she identifies and implemented a new biomarker for early diagnosis of patients with acute myeloid leukemia (AML). As a leader and contributor in international projects, she supports implementing translational science strategy for new cell therapies in oncology. Her scientific interest is aimed at designing and applying concepts of personalized medicine to predict and treat malignancies.
A.V.Palladin Institute of Biochemistry of Ukraine Academy Sciences.Ukraine
I was born at 01.08.1936. At 1966 I have graduated from M.I.Pirogov Vinitsa National Medical University. I worked manager of the hospital in Sum district of Ukraine and then doctor of therapeutic department in the Kiev regional hospital. Then I have graduated from Kiev national Institute of post diploma education and Lvov National Medical University, faculties of laboratory clinical diagnostics, laboratory clinical biochemistry, laboratory toxicology. At 1969 I worked scientific employee at A.V.Palladin Institute of Biochemistry of Ukraine Academy Sciences in the department "Biochemistry of Growth". At 1972 - 1990 I worked head of clinical and biochemical laboratory of the First Kiev regional hospital, and I have obtained Degree PhD from 1990. At 1990 - 2002 I worked head of toxicological and biochemical Laboratory of the Kiev regional p/n hospital. Working in the hospitals, I co-operated with department "Structure and functions of proteins" AV.Palladin Institute of Biochemistry Academy Sciences of Ukraine and have published some scientific articles in the Journals "Bulletin of the experimental biology and medicine" and “Laboratory Affairs” together with employees of the department. Besides I have published a lot of scientific articles in the scientific journal named “Actual Problems of Biology and Medicine” of A.A.Bogomoletz Kiev national medical University. Since 2002 I have retired. At 2002 I have left Kiev (Ukraine) for Germany where I have published some scientific works. There are my area of interest and also research expertise area: Thermodynamics of a human organism in norm and pathology; Biochemical and Biophysical metabolic mechanisms in a human organism and in cells of an organism in norm; Biochemical and Biophysical metabolic mechanisms in a human organism and in cells of an organism in pathology, especially cancer pathology.
Medical University of Warsaw, Poland
Dr. Miroslaw Szczepanski is an associate professor in the Department of Biochemistry, Medical University of Warsaw, Poland. He is also Polish-board certified otolaryngologist. Dr. Szczepanski received medical and graduate (PhD) training in immunology in the MD/PhD program at the Poznan University of Medical Sciences, Poznan, Poland. He underwent residency training in Otolaryngology–Head and Neck Surgery at the Department of Otolaryngology at the Medical University of Warsaw, Poland. Dr. Szczepanski has received research awards from the Rector of Medical University of Warsaw, Polish Ministry of Health and from the Polish ENT Society. His research is focused on tumor immunology and immunology of chronic inflammation. His clinical practice is focused on endoscopic sinus surgery and endoscopic orbital decompression in the course of Graves’ orbitopathy. Dr. Szczepanski's passion is scuba-diving and the underwater world.
National Public Health Center, Hungary
Professor Anna Tompa was graduated in medicine in Budapest Semmelweis Medical University and became an assistant professor at the Institute of Pathology and Cancer Research of the School of Medicine. After specialized in pathology she went to the United States to study the advanced methodology of experimental cancer research. She has continued her research activities focused on the cancer prevention and obtained her D.Sc. in 1999 from Hungarian Academy of Sciences. She has written more, than 160 publications and given about 200 scientific lectures in different domestic and international congresses. She is a member of numerous domestic and international scientific societies, and presently she is emeritus fellow of Ramazzini Collegium and OECD expert in chemical safety. Today she is an emeritus professor of Public Health Institute in the Semmelweis University, Budapest, Hungary.
Johns Hopkins Aramco Healthcare, Saudi Arabia
Huda Alsayed Ahmed's background in medical laboratory sciences has a Ph.D. in Molecular Medicine. Her main expertise is in Flowcytometry, Molecular genetics, research science, and international review board & ethics. She got a qualification certificate in healthcare quality from the “American Institute of healthcare management agency”. Her recent expertise as a healthcare quality specialist, assigned to the oncology area at Johns Hopkins Aramco Healthcare (JHAH) -Saudi Arabia, is in improving the healthcare service and process in oncology institute/cancer center at JHAH in addition to her job as accreditation coordinator. This abstract summarizes a quality improvement initiative held in oncology at JHAH last year using evidence-based practice.
Institute for Blood Transfusion of Vojvodina, Novi Sad, Serbia
Dr Gradimir Dimitrijevic has 30 years’ experience in transfusion medicine, most of the time as expert in clinical transfusion but with very good experience in therapeutic apheresis, and blood component therapy. From few years ago introduced irradiation in Serbia ,in Novi Sad, and most of the blood components that are irradiated are for oncology, hematology in adults and children. That is his experience in all this together.
Cancer Society of MP, India
• National Chairman-IMA Cancer & Tobacco Control Committee
• Chairman-IMA MP State Committee on Organ Donation
• Chairman-IMA MP State Cancer & Tobacco Control Committee
• Patron, Voice of Tobacco Victims (VOTV)
• Hon.Secretary- Cancer Society of Madhya Pradesh
• President-Alumni Association of KEH Medical School & MGM Medical College, Indore
• Hon.Secretary Trustee, Indore Surgeons Research Foundation • Surgical Specialist-Ex Civil Surgeon, Dept. Of Public Health & Family Welfare, Indore
National Cancer Institute, Brazil
Roberto André Torres de Vasconcelos MD, MSc, PhD Orthopedic Oncologist surgeon who has been working for 20 years in the treatment of patients with musculoskeletal tumors at the National Cancer Institute of Brazil, for 10 years research on malignant peripheral nerve sheath tumor in patients with and without neurofibromatosis type 1
Cancer Patients Aid Association, Worli, Mumbai, India.
Dr. Dhananjaya Saranath, Ph.D., FMAS (Fellow of the Maharashtra Academy of Sciences), has extensive experience in Molecular Oncology with pioneering work of almost four decades in unravelling the molecular basis of oral cancer. She was elected as Member-at-Large, Council of the International Academy of Oral Oncology, and was President of the Indian Association of Cancer Research Dr. Saranath is a member of several scientific advisory councils of national institutes. She has done pioneering work towards understanding the ‘Molecular basis of oral cancer’. Her areas of interest include Cervical Cancer, Breast Cancer, Oral Cancer Non-Hodgkin’s lymphoma, Chronic Myeloid leukaemia’s and additional areas in Biomedical Sciences. She has been awarded several National and International awards, and authored more than 105 publications in peer reviewed journals and several chapters in books, as well as edited a book on ‘Contemporary Issues in Oral Cancer, Oxford Press, 2000. She has successfully mentored 25 students for their Ph.D. research projects. She is a Chief Editor (along with a colleague) of ‘Biomedical Research Journal’, an interdisciplinary, peer reviewed journal. Her current focus in translational medicine, and is actively involved in identifying bio molecular markers in several cancers. Besides, her team is analysing small drug-like molecules to define novel therapeutic approaches in oral cancer. A critical focus of her group is ‘Elimination of Cervical Cancer through ‘Cancer Awareness‘, Cervical Cancer Screening’ and ‘HPV Vaccination’. at no cost to low socio-economic under privileged females.
Armed Forces Hospital in The Southern Region of Saudi Arabia,
Enas A Dhaher is an assistant professor and Dean of the Nursing College at the Armed Forces Hospital Southern Region in Saudi Arabia. She received her PhD from the Bielefeld University, Germany in 2008, and her MPH from the Netherlands School of Public Health- The Netherlands in 1999. She previously worked as Dean for Al-Ghad Health Science Colleges in Dammam –Saudi Arabia, and as assistant professor at Irbid National University –Jordan. Her research interest is mainly on women’s health, reproductive health, reproductive health rights and domestic violence
Sismanogleio-Amalia Flemig General Hospital, Greece.
Vasileios Panteris is a Consultant Gastroenterologist with a special interest in interventional endoscopy and public health issues. He works in a tertiary hospital in the area of Athens. He has made scientific contributions in many recent guidelines in his area of interest by way of relevant publications and recently has been occupied with colorectal screening requirements in Greece through the National School of Public Health.
Charles University, Prague, Czech Republic
Jan Kovar, cell and molecular biologist, graduated in biology, Charles University, Prague, Czech Republic. Between 1986-1995 he spent nearly 4 years as a visiting scientist in the USA. In 1991 he became the head of Cell Growth Control Laboratory at the Institute of Molecular Genetics, Prague. Since 2003 he is the head of the Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague. Since 2007 he is a full professor at the Charles University, Prague. He is a member of several international professional societies (e.g. International Cell Death Society) and a council member of the European Cell Proliferation Society. He is involved in research concerning molecular mechanisms of apoptosis induction in cancer cells and molecular mechanisms of resistance of cancer cells to apoptosis induction.
King Fahad Specialist Hospital-Dammam, Saudi Arabia
After achieving his bachelor degree in medicine and surgery, Dr.Hamoud has enrolled in several residency and fellowship training programs, including residency in Pathology, Clinical Biochemical Genetics and Clinical Molecular Genetics fellowships. He has been appointed as the director of Molecular Diagnostics Laboratory at King Fahad Specialist Hospital-Dammam, Saudi Arabia. During his career, he held several research related positions nationally and international. He is holding several American and Canadian boards in Medical Biochemistry, Clinical Chemistry, Clinical Biochemical Genetics, Clinical Molecular Genetics and Molecular Diagnostics. His interests include, Metabolism, Biochemical Pathways in Physiology and Cancer, Molecular Genetics of Tumors, and Inherited Molecular and Biochemical Disorders.
Shahid Chamran University of Ahvaz, Iran
Najmeh Hamid is an author, researcher, writer & master of clinical psychology & psychotherapy in Shahid Chamran University Certified official recruiting with 29 years of experience. She was born in IRAN, she has wide abroad researched in the field of clinical psychology, brain performance such as memory and concentration, personality, psychological assessment, neuropsychology, cognitive behavior therapy(CBT) and any other therapeutic methods.
Najmeh Hamid is a well-known character in Iran, particularly for psychotherapy, researches and using neurofeedback for ADHD children and adults. Her books are the source for students and researchers’. Her lectures and teachings which have been done in universities, Institutes and Radio and Television of Iran
Institute of Graduate Studies and Research (IGSR)
Dr. Mohammed Moustapha completed his BSc degree in pharmaceutical sciences in 2012 at the University of Alexandria. He also completed his internship in 2015 in drug discovery and drug design from India. He is currently a member of the European Society for Medical Oncology (ESMO) and a MSc student at the Department of biotechnology at the institute of graduate studies and research (IGSR). He has been working as a senior medical researcher and scientific associate for more than 2 years and is currently serving as a medical program lead for the MENA region in pharmaceutical consultancy. He is also a research fellow in health technology assessment (HTA), pricing, healthcare policy, and health economy and outcomes research (HEOR).
Bharati Vidyapeeth College of Pharmacy, India
Prof. Gaikwad has his expertise in formulation and development of novel phytoformulations. He has developed PECTIN-PVP CUR particulates which may suitable for local delivery and enhance anticancer potential of curcumin. The thought-provoking academic talks delivered by Prof. Gaikwad as an invited speaker during national and international conferences reflect his excellent oratory and communication skills. He is currently Assistant Professor in Pharmaceutics Department, Bharati Vidyapeeth College of Pharmacy, Kolhapur, India and achieved excellence in new drug delivery systems. With over several years’ experience in the field of natural products and formulation research, he has more than 20 research publications, 2 formulation patents and 2 book chapters to his credit.